Evaluation of Efficacy and Safety Topical 5-Fluorouracil 0.5% in Treatment of Resistant Vitiligo [Alone or After Microneedling]; A pilot Study
Background: Vitiligo is a chronic acquired disorder characterized by the depigmented macules. There are many treatment options, but the response is variable and unsatisfactory. Topical 5-fluorouracil used in many dermatological diseases but, this is the first study to date that use 0.5% concentratio...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Al-Azhar University, Faculty of Medicine (Damietta)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/11f0ba5ad10643589c16b9384fb5f977 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:11f0ba5ad10643589c16b9384fb5f977 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:11f0ba5ad10643589c16b9384fb5f9772021-12-02T19:33:14ZEvaluation of Efficacy and Safety Topical 5-Fluorouracil 0.5% in Treatment of Resistant Vitiligo [Alone or After Microneedling]; A pilot Study2636-41742682-378010.21608/ijma.2021.89242.1347https://doaj.org/article/11f0ba5ad10643589c16b9384fb5f9772021-10-01T00:00:00Zhttps://ijma.journals.ekb.eg/article_193556_6106a3e936814afda52fe162013069db.pdfhttps://doaj.org/toc/2636-4174https://doaj.org/toc/2682-3780Background: Vitiligo is a chronic acquired disorder characterized by the depigmented macules. There are many treatment options, but the response is variable and unsatisfactory. Topical 5-fluorouracil used in many dermatological diseases but, this is the first study to date that use 0.5% concentration in vitiligo treatment.The Aim of The Work: This study evaluates efficacy and safety topical 5-fluorouracil in 0.5% concentration in treatment of resistant vitiligo either alone or after microneedling.Subject and Methods: 30 patients with resistant vitiligo were enrolled into the study; we studied only 2 patches in every patient. The first patch treated with one session of microneedling followed by topical 5-fluorouracil 0.5% once daily for 2 weeks. The second patch treated with topical 5-fluorouracil 0.5% only for 2 weeks, then follow up of both patches for 3 months.Results: Excellent response achieved in 46.7% of the patches treated with microneedling followed by topical 5-fluorouracil 0.5%, while only in 23.3% of the patches treated with topical 5-fluorouracil 0.5% alone. There was no significant difference between both groups regarding response, despite this the degree of improvement was higher in combined treatment.Conclusion: Topical 5-fluorouracil 0.5% is an effective and safe in treatment of resistant vitiligo and combined therapy increases the efficacy.Sara GalalMoshiraly AliFatma ElzeinyAl-Azhar University, Faculty of Medicine (Damietta)article5-fluorouracil 0.5%microneedlingpigmentationvitiligoMedicine (General)R5-920ENInternational Journal of Medical Arts, Vol 3, Iss 4, Pp 1803-1810 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
5-fluorouracil 0.5% microneedling pigmentation vitiligo Medicine (General) R5-920 |
spellingShingle |
5-fluorouracil 0.5% microneedling pigmentation vitiligo Medicine (General) R5-920 Sara Galal Moshiraly Ali Fatma Elzeiny Evaluation of Efficacy and Safety Topical 5-Fluorouracil 0.5% in Treatment of Resistant Vitiligo [Alone or After Microneedling]; A pilot Study |
description |
Background: Vitiligo is a chronic acquired disorder characterized by the depigmented macules. There are many treatment options, but the response is variable and unsatisfactory. Topical 5-fluorouracil used in many dermatological diseases but, this is the first study to date that use 0.5% concentration in vitiligo treatment.The Aim of The Work: This study evaluates efficacy and safety topical 5-fluorouracil in 0.5% concentration in treatment of resistant vitiligo either alone or after microneedling.Subject and Methods: 30 patients with resistant vitiligo were enrolled into the study; we studied only 2 patches in every patient. The first patch treated with one session of microneedling followed by topical 5-fluorouracil 0.5% once daily for 2 weeks. The second patch treated with topical 5-fluorouracil 0.5% only for 2 weeks, then follow up of both patches for 3 months.Results: Excellent response achieved in 46.7% of the patches treated with microneedling followed by topical 5-fluorouracil 0.5%, while only in 23.3% of the patches treated with topical 5-fluorouracil 0.5% alone. There was no significant difference between both groups regarding response, despite this the degree of improvement was higher in combined treatment.Conclusion: Topical 5-fluorouracil 0.5% is an effective and safe in treatment of resistant vitiligo and combined therapy increases the efficacy. |
format |
article |
author |
Sara Galal Moshiraly Ali Fatma Elzeiny |
author_facet |
Sara Galal Moshiraly Ali Fatma Elzeiny |
author_sort |
Sara Galal |
title |
Evaluation of Efficacy and Safety Topical 5-Fluorouracil 0.5% in Treatment of Resistant Vitiligo [Alone or After Microneedling]; A pilot Study |
title_short |
Evaluation of Efficacy and Safety Topical 5-Fluorouracil 0.5% in Treatment of Resistant Vitiligo [Alone or After Microneedling]; A pilot Study |
title_full |
Evaluation of Efficacy and Safety Topical 5-Fluorouracil 0.5% in Treatment of Resistant Vitiligo [Alone or After Microneedling]; A pilot Study |
title_fullStr |
Evaluation of Efficacy and Safety Topical 5-Fluorouracil 0.5% in Treatment of Resistant Vitiligo [Alone or After Microneedling]; A pilot Study |
title_full_unstemmed |
Evaluation of Efficacy and Safety Topical 5-Fluorouracil 0.5% in Treatment of Resistant Vitiligo [Alone or After Microneedling]; A pilot Study |
title_sort |
evaluation of efficacy and safety topical 5-fluorouracil 0.5% in treatment of resistant vitiligo [alone or after microneedling]; a pilot study |
publisher |
Al-Azhar University, Faculty of Medicine (Damietta) |
publishDate |
2021 |
url |
https://doaj.org/article/11f0ba5ad10643589c16b9384fb5f977 |
work_keys_str_mv |
AT saragalal evaluationofefficacyandsafetytopical5fluorouracil05intreatmentofresistantvitiligoaloneoraftermicroneedlingapilotstudy AT moshiralyali evaluationofefficacyandsafetytopical5fluorouracil05intreatmentofresistantvitiligoaloneoraftermicroneedlingapilotstudy AT fatmaelzeiny evaluationofefficacyandsafetytopical5fluorouracil05intreatmentofresistantvitiligoaloneoraftermicroneedlingapilotstudy |
_version_ |
1718376364550127616 |